Page last updated: 2024-10-30

lansoprazole and Carcinoma

lansoprazole has been researched along with Carcinoma in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsukamoto, H1
Mizoshita, T1
Sasaki, M1
Mizushima, T1
Tanida, S1
Ozeki, K1
Hirata, Y1
Shimura, T1
Kataoka, H1
Kamiya, T1
Nojiri, S1
Tsukamoto, T1
Tatematsu, M1
Joh, T1

Other Studies

1 other study available for lansoprazole and Carcinoma

ArticleYear
Long-term high-dose proton pump inhibitor administration to Helicobacter pylori-infected Mongolian gerbils enhances neuroendocrine tumor development in the glandular stomach.
    Asian Pacific journal of cancer prevention : APJCP, 2011, Volume: 12, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Carcinoma; Cell Transformation, Neoplastic; Chromo

2011